Fast Fact Product Reviews

One of our products – isophosphoramide mustard (IPM) – that was licensed to ZIOPHARM Oncology, Inc. – now known as ‘Palifosfamide’ is moving nicely in Phase III trials. DEKK-TEC was awarded a US patent 7,678,778 for drug composition of matter and the concept. A recent presentation, which received a ‘PICASSO’ award, can be viewed by [...]

DEKK-TEC News

Fast Fact Product Reviews

One of our products – isophosphoramide mustard (IPM) – that was licensed to ZIOPHARM Oncology, Inc. – now known as ‘Palifosfamide’ is moving nicely in Phase III trials. DEKK-TEC was awarded a US patent 7,678,778 for drug composition of matter and the concept. A recent presentation, which received a ‘PICASSO’ award, can be viewed by [...]

read more >>